Bill
SF 5302
Prescription drugs prices establishment subject to the Medicare Drug Price Negotiation Program
2025-2026 Regular Session
Introduced by Liz Boldon and 2 co-sponsors
Minnesota caps prices for certain drugs at the federal maximum fair price (plus dispensing fees) or NADAC, requires disclosures to the affordability board, and bans drug withdrawal
Referred to Health and Human Services